Genetically modified (GM) salmon producer AquaBounty is offering $10 million (€8.9 million) worth of shares of its common stock to investors, the company said Wednesday.

AquaBounty intends to use the capital to continue constructions and renovation at its Rollo Bay and Indiana facilities, as well as invest in sales, marketing and research and development.

The closing sale price of the Nasdaq-listed stock was $2.66 (€2.39) per share on Jan. 14. The company expects 25.3 million shares to be outstanding after the offer.